Carlos Javier Alméciga-Díaz (Carlos J Alméciga-Díaz, Carlos J Alméciga-Diaz)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Gene therapy

Scientific reports

Vaccines

Pontificia Universidad Javeriana

Pontificia Universidad Javeriana (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pontificia Universidad Javeriana Jun 09 2009

Colombia

Profesor Asociado - Director IEIM :: Instituto de Errores Innatos del Metabolismo

Education History

Pontificia Universidad Javeriana Aug 01 2004 - Apr 10 2009

Colombia

PHD :: Ciencias

Publications

Juan Sebastian Quintero Barbosa, Carlos Javier Alméciga-Díaz, Sandra E Pérez, Maria Fernanda Gutierrez
Humoral Immune Response of Mice against a Vaccine Candidate Composed of a Chimera of gB of Bovine Alphaherpesviruses 1 and 5. Vaccines 11 (7) (2023)
Andrés Felipe Leal, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks. International journal of molecular sciences 24 (22) (2023)
Andrés Felipe Leal, Javier Cifuentes, Valentina Quezada, Eliana Benincore-Flórez, Juan Carlos Cruz, Luis Humberto Reyes, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz
CRISPR/nCas9-Based Genome Editing on GM2 Gangliosidoses Fibroblasts via Non-Viral Vectors. International journal of molecular sciences 23 (18) (2022)
Andrés Felipe Leal, Carlos Javier Alméciga-Díaz
Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA. Gene therapy (2022)
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. International journal of molecular sciences 24 (1) (2022)
Andres Ceballos-Garzon, Elvira Roman, Jesús Pla, Fabrice Pagniez, Daniela Amado, Carlos Javier Alméciga-Díaz, Patrice Le Pape, Claudia Marcela Parra-Girado
CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata. PloS one 17 (3) (2022)
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. International journal of molecular sciences 24 (1) (2022)
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. International journal of molecular sciences 24 (1) (2022)
Andrés Felipe Leal, Javier Cifuentes, Carlos Emilio Torres, Diego Suárez, Valentina Quezada, Saúl Camilo Gómez, Juan Carlos Cruz, Luis Humberto Reyes, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz
Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles. Scientific reports 12 (1) (2022)
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. International journal of molecular sciences 24 (1) (2022)
Andrés Felipe Leal, Angela Johana Espejo-Mojica, Oscar F Sanchez, Carlos Manuel Ramírez, Luis Humberto Reyes, Juan Carlos Cruz, Carlos Javier Alméciga-Díaz
Lysosomal storage diseases: current therapies and future alternatives. Journal of molecular medicine (Berlin, Germany) 98 (7) (2020)
Angela Johana Espejo-Mojica, Edwin Alexander Rodriguez-López, Rong Li, Wei Zheng, Carlos Javier Alméciga-Díaz, Cindy Dulcey-Sepúlveda, Germán Combariza, Luis A Barrera
Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts. American journal of medical genetics. Part C, Seminars in medical genetics 184 (4) (2020)
Andrés Felipe Leal, Eliana Benincore-Flórez, Daniela Solano-Galarza, Rafael Guillermo Garzón Jaramillo, Olga Yaneth Echeverri-Peña, Diego A Suarez, Carlos Javier Alméciga-Díaz, Angela Johana Espejo-Mojica
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. International journal of molecular sciences 21 (17) (2020)
Carlos Javier Alméciga-Díaz, Oscar A Hidalgo, Sergio Olarte-Avellaneda, Alexander Rodríguez-López, Esteban Guzman, Rafael Garzón, Luisa Natalia Pimentel-Vera, María Alejandra Puentes-Tellez, Andrés Felipe Rojas-Rodriguez, Kirill Gorshkov, Rong Li, Wei Zheng
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of medicinal chemistry 62 (13) (2019)
Carlos Javier Alméciga-Díaz, Luis A Barrera
Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia. Gene therapy 27 (1-2) (2019)
Juan Camilo Losada Díaz, Jacobo Cepeda Del Castillo, Edwin Alexander Rodriguez-López, Carlos Javier Alméciga-Díaz
Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses. International journal of molecular sciences 21 (1) (2019)
Natalia Pimentel, Alexander Rodríguez-Lopez, Sergio Díaz, Juan C Losada, Dennis J Díaz-Rincón, Carolina Cardona, Ángela J Espejo-Mojica, Aura M Ramírez, Fredy Ruiz, Patricia Landázuri, Raúl A Poutou-Piñales, Henry A Cordoba-Ruiz, Carlos Javier Alméciga-Díaz, Luis A Barrera-Avellaneda
Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris. Biotechnology and applied biochemistry 65 (5) (2018)
Olga Y Echeverri, Johana M Guevara, Ángela J Espejo-Mojica, Andrea Ardila, Ninna Pulido, Magda Reyes, Alexander Rodriguez-Lopez, Carlos Javier Alméciga-Díaz, Luis A Barrera
Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center. Orphanet journal of rare diseases 13 (1) (2018)
Luis Humberto Reyes, Carolina Cardona, Luisa Pimentel, Edwin Alexander Rodriguez-López, Carlos Javier Alméciga-Díaz
Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches. Scientific reports 7 (1) (2017)
Dennis J Díaz-Rincón, Ivonne Duque, Erika Osorio, Alexander Rodríguez-López, Angela Espejo-Mojica, Claudia M Parra-Giraldo, Raúl A Poutou-Piñales, Carlos Javier Alméciga-Díaz, Balkys E Quevedo-Hidalgo
Production of Recombinant Trichoderma reesei Cellobiohydrolase II in a New Expression System Based on Wickerhamomyces anomalus. Enzyme research 2017 (2017)
Sergio Olarte-Avellaneda, Alexander Rodríguez-López, Juan David Patiño, Carlos Javier Alméciga-Díaz, Oscar F Sánchez
In Silico Analysis of the Structure of Fungal Fructooligosaccharides-Synthesizing Enzymes. Interdisciplinary sciences, computational life sciences 10 (1) (2016)

Carlos Javier Alméciga-Díaz.css-eqlu8i{font-size:small;padding-left:4px;} (Carlos J Alméciga-Díaz, Carlos J Alméciga-Diaz)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Javier Alméciga-Díaz (Carlos J Alméciga-Díaz, Carlos J Alméciga-Diaz)